Literature DB >> 16472690

Lentiviral delivery of RNAi in hippocampal neurons.

Justyna Janas1, Jacek Skowronski, Linda Van Aelst.   

Abstract

The breakthrough discovery that double-stranded RNA of 21 nucleotides in length (referred to as short or small interfering RNA; siRNA) can trigger sequence-specific gene silencing in mammalian cells has led to the development of a powerful new approach to study gene function (Dillon et al., 2005; Dykxhoorn et al., 2003; Elbashir et al., 2001; Hannon et al., 2004). Effective delivery of siRNA molecules into target cells or tissues is critical for successful RNA interference (RNAi) application. Here, we describe the use of human immunodeficiency virus type 1 (HIV-1)-based lentiviral vectors for delivery of short hairpin RNA (shRNA), a precursor of siRNA, into primary neurons to suppress gene expression. Major advantages of lentiviral vectors are their ability to transduce nondividing cells and to confer long-term expression of transgenes. This chapter covers selection of short hairpin sequences, vector design, production of lentiviral supernatants, transduction of dissociated primary hippocampal neurons, and testing the effectiveness of shRNA-mediated silencing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472690     DOI: 10.1016/S0076-6879(06)06046-0

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  24 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Efficient and graded gene expression in glia and neurons of primary cerebellar cultures transduced by lentiviral vectors.

Authors:  Sujeet Kumar; Katrin Zimmermann; Hiroyuki Hioki; Alexander Pfeifer; Stephan L Baader
Journal:  Histochem Cell Biol       Date:  2014-08-26       Impact factor: 4.304

4.  Axo-axonic Innervation of Neocortical Pyramidal Neurons by GABAergic Chandelier Cells Requires AnkyrinG-Associated L1CAM.

Authors:  Yilin Tai; Nicholas B Gallo; Minghui Wang; Jia-Ray Yu; Linda Van Aelst
Journal:  Neuron       Date:  2019-03-04       Impact factor: 17.173

5.  Organization of amyloid-beta protein precursor intracellular domain-associated protein-1 in the rat brain.

Authors:  Amanda L Jacob; Bryen A Jordan; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2010-08-15       Impact factor: 3.215

6.  Chronic ethanol up-regulates the synaptic expression of the nuclear translational regulatory protein AIDA-1 in primary hippocampal neurons.

Authors:  Patrick J Mulholland; Bryen A Jordan; L Judson Chandler
Journal:  Alcohol       Date:  2012-06-14       Impact factor: 2.405

7.  RNA-binding protein Sam68 controls synapse number and local β-actin mRNA metabolism in dendrites.

Authors:  Matthew E Klein; Thomas J Younts; Pablo E Castillo; Bryen A Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

8.  The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury.

Authors:  Jinhui Li; Yi Qu; Xihong Li; Deyuan Li; Fengyan Zhao; Meng Mao; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

9.  Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity.

Authors:  Dana O Kravchick; Anna Karpova; Matous Hrdinka; Jeffrey Lopez-Rojas; Sanda Iacobas; Abigail U Carbonell; Dumitru A Iacobas; Michael R Kreutz; Bryen A Jordan
Journal:  EMBO J       Date:  2016-07-25       Impact factor: 11.598

10.  The Use of Lentiviral Vectors and Cre/loxP to Investigate the Function of Genes in Complex Behaviors.

Authors:  Scott A Heldt; Kerry J Ressler
Journal:  Front Mol Neurosci       Date:  2009-11-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.